[1]
“Estimation of the restriction period after radiological discharge of patients undergoing metabolic therapy with [177Lu]Lu-DOTA-TATE and [177Lu]Lu-PSMA-617”, Rev Fis Med, vol. 26, no. 2, pp. 27–36, Nov. 2025, doi: 10.37004/sefm/2025.26.2.002.